Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of IMCB recommended dividends

10/31/24 GEMA

Ozon Pharmaceuticals reported for 9 months of 2024 by RAS

10/31/24 OZPH

X5 Group opened its 700th OKOLO store

10/31/24 FIVE

Ozon launched a logistics complex in Yaroslavl

10/31/24 OZON

Pyatyorochka opened in Buryatia

10/31/24 FIVE

Fix Price may offer to exchange receipts for shares in the operating company

10/31/24 FIXP

Fix Price reported for 9 months of 2024

10/31/24 FIXP

Fix Price's LFL sales grew 1.2% in 9 months

10/31/24 FIXP

Sberbank reported for 9 months of 2024 by IFRS

10/31/24 SBER

Moscow Exchange reported for 9 months of 2024 by RAS

10/31/24 MOEX